Study Reveals How Egyptian Rousette Bats Generate Antibodies Against H9 Influenza
Researchers developed tools to study antibody responses in Egyptian rousette bats exposed to H9 influenza, isolating and characterizing monoclonal antibodies from bat immune cells. Bats are known reservoirs for zoonotic viruses but tolerate infections without severe disease, making understanding their immune mechanisms important for pandemic preparedness. The findings provide insights into how bat adaptive immunity differs from humans and could help predict spillover risks for other bat-borne viruses.
Scientists created a yeast surface display library using RNA from wild-caught Egyptian rousette bat spleens to study how these animals generate antibodies against bat-derived H9 influenza hemagglutinin. The team isolated monoclonal antibodies, analyzed their genetic characteristics, mutation frequencies, binding strengths, and breadth of recognition, then used cryo-electron microscopy to visualize three bat antibodies bound to the influenza antigen at different sites. The research reveals both similarities and differences between bat and human antibody responses to influenza, providing a new platform for examining how bats mount immune defenses against potential zoonotic viruses. Since bats tolerate infections that would cause severe disease in other mammals, understanding their antibody-mediated immunity could illuminate why they serve as effective viral reservoirs and inform strategies for assessing spillover risks.
What's missing
The article does not specify whether these bat antibodies are more or less effective at neutralizing H9 influenza compared to human antibodies, nor does it discuss the timeline for when these findings might inform practical public health applications. Additionally, there is limited discussion of how frequently Egyptian rousette bats encounter H9 influenza in nature or what role this virus plays in bat populations.
What different sources said
- bioRxivCenter
Egyptian rousette bat humoral immunity to H9 influenza hemagglutinin
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.